Cannabinoid-AED combinations can enhance seizure protection but also increase side effects, with CBD clinical trials showing 14-35% dropout rates and common side effects of diarrhea, somnolence, and poor appetite.
Epileptologists, pharmacists managing AED regimens, and patients on CBD plus AEDs.
14-35% retention rate for CBD add-on
What the researchers found
In animal models, WIN 55,212-2 (CB1/CB2 agonist) potentiated anticonvulsant activity of various AEDs but caused profound neurotoxicity when combined with conventional AEDs. ACEA (selective CB1 agonist) enhanced phenobarbital and levetiracetam without adverse effects or pharmacokinetic interactions. Clinical CBD add-on therapy reduced seizure frequency with retention rates of 14-24% at 12 weeks to 1 year, reaching 35% at 2 years.
Why it matters
Most epilepsy patients on CBD are taking multiple other medications. Understanding which combinations are safe and effective is critical for clinical practice, especially as CBD use in epilepsy grows rapidly.
The numbers in context
Clinical CBD retention rate: 14-24% (12 weeks to 1 year), 35% at 2 years. Most common AEs: diarrhea, somnolence, poor appetite. ACEA enhanced phenobarbital and levetiracetam without pharmacokinetic interactions in mice.
How the study worked
Literature review of PubMed through December 2018, covering both experimental (animal model) and clinical data on AED-cannabinoid interactions.
What this study cannot tell us
Animal interaction data may not translate directly to humans. Clinical retention rates reflect a mix of efficacy and tolerability. Limited pharmacokinetic interaction data in humans.
How to read the evidence
Moderate: comprehensive review of both experimental and clinical data.
When this study was published
Published in 2019.
The bigger picture
The distinction between CB1/CB2 non-selective agonists (toxic combinations) and selective CB1 agonists (clean combinations with certain AEDs) has practical implications for developing safer cannabinoid-AED combinations.
Questions still open
- Which specific AED-CBD combinations have the best efficacy-safety profile? Can selective CB1 agonists be developed for clinical use in epilepsy?
Common questions
Does CBD interact with seizure medications?
Are some cannabinoid-AED combinations safer?
Read the original research
Drug-drug interactions between antiepileptics and cannabinoids.
Expert opinion on drug metabolism & toxicology, 15(5), 407-415
Citation
Miziak, Barbara; Walczak, Aleksandra; Szponar, Jarosław; Pluta, Ryszard; Czuczwar, Stanisław J. (2019). Drug-drug interactions between antiepileptics and cannabinoids.. Expert opinion on drug metabolism & toxicology, 15(5), 407-415. https://doi.org/10.1080/17425255.2019.1605355
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk